Summary of Key Points Core Viewpoint - The announcement details the provision of a guarantee by Qingdao Weilan Biological Co., Ltd. for its subsidiary, Qingdao Weilan Longchu Biotechnology Co., Ltd., to support its credit activities with a total guarantee amount of RMB 178,950.00 million for the fiscal year 2025 [1][2]. Group 1: Guarantee Overview - The guaranteed entity is Qingdao Weilan Longchu Biotechnology Co., Ltd. [1] - The total guarantee amount provided is RMB 178,950.00 million, with the current balance being reported [2]. - The guarantee does not have any counter-guarantee [1]. - There are no overdue guarantees reported [1]. Group 2: Approval Process - The guarantee was approved by the company's board meeting on April 25, 2025, and subsequently by the annual shareholders' meeting on May 16, 2025 [2]. - The details of the guarantee were disclosed in announcements on April 26, 2025, and May 17, 2025 [2]. Group 3: Financial Status of the Guaranteed Entity - Qingdao Weilan Longchu Biotechnology Co., Ltd. was established on August 11, 2011, with a registered capital of RMB 33.50 million [3]. - The total assets of the company are reported at RMB 79,627.70 million, with total liabilities at RMB 41,997.90 million, resulting in net assets of RMB 37,629.80 million [4]. - The company's revenue for the audited period is RMB 83,549.20 million, with a net profit of RMB 4,286.00 million [4]. Group 4: External Guarantee Status - The total amount of external guarantees provided by the company and its subsidiaries is RMB 91,420.00 million, which constitutes 52.61% of the net assets attributable to shareholders as of December 31, 2024 [4][5]. - There are no overdue guarantees as of the announcement date [5].